edoc

Items where contributor is "Mehling, Matthias"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

2018

Bigler, Marc B. and Hirsiger, Julia R. and Recher, Mike and Mehling, Matthias and Daikeler, Thomas and Berger, Christoph T.. (2018) Varicella Zoster Virus specific T cell responses in untreated Giant Cell Arteritis: comment on the article by England et al. Arthritis & rheumatology, 70 (2). pp. 318-320.

2017

Kistner, Anne and Bigler, Marc B. and Glatz, Katharina and Egli, Simon B. and Baldin, Fabian S. and Marquardsen, Florian A. and Mehling, Matthias and Rentsch, Katharina M. and Staub, Daniel and Aschwanden, Markus and Recher, Mike and Daikeler, Thomas and Berger, Christoph T.. (2017) Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis. Rheumatology, 56 (5). pp. 829-834.

Navarini, Alexander A. and Hruz, Petr and Berger, Christoph T. and Hou, Tie Zheng and Schwab, Charlotte and Gabrysch, Annemarie and Higgins, Rebecca and Frede, Natalie and Padberg Sgier, Barbara-Christina and Kämpe, Olle and Burgener, Anne-Valérie and Marquardsen, Florian and Baldin, Fabian and Bigler, Marc and Kistner, Anne and Jauch, Annaise and Bignucolo, Olivier and Meyer, Benedikt and Meienberg, Fabian and Mehling, Matthias and Jeker, Lukas T. and Heijnen, Ingmar and Daikeler, Thomas D. and Gebbers, Jan-Olaf and Grimbacher, Bodo and Sansom, David M. and Jeker, Raphael and Hess, Christoph and Recher, Mike. (2017) Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. Journal Of Allergy And Clinical Immunology, 139 (3). pp. 1043-1046e5.

2016

Dimeloe, S. and Mehling, M. and Frick, C. and Loeliger, J. and Bantug, G. R. and Sauder, U. and Fischer, M. and Belle, R. and Develioglu, L. and Tay, S. and Langenkamp, A. and Hess, C.. (2016) The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions. J Immunol, 196 (1). pp. 106-114.

Hegen, Harald and Adrianto, Indra and Lessard, Christopher J. and Millonig, Alban and Bertolotto, Antonio and Comabella, Manuel and Giovannoni, Gavin and Guger, Michael and Hoelzl, Martina and Khalil, Michael and Fazekas, Franz and Killestein, Joep and Lindberg, Raija L.P. and Malucchi, Simona and Mehling, Matthias and Montalban, Xavier and Rudzki, Dagmar and Schautzer, Franz and Sellebjerg, Finn and Sorensen, Per Soelberg and Deisenhammer, Florian and Steinman, Lawrence and Axtell, Robert C.. (2016) Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients. Neurol Neuroimmunol Neuroinflamm, 3 (2). e202.

Schwarz, Jan and Bierbaum, Veronika and Merrin, Jack and Frank, Tino and Hauschild, Robert and Bollenbach, Tobias and Tay, Savaş and Sixt, Michael and Mehling, Matthias. (2016) A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients. Scientific Reports, 6. p. 36440.

2015

Berger, Christoph T. and Greiff, Victor and Mehling, Matthias and Fritz, Stefanie and Meier, Marc A. and Hoenger, Gideon and Conen, Anna and Recher, Mike and Battegay, Manuel and Reddy, Sai T. and Hess, Christoph. (2015) Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection. Human Vaccines & Immunotherapeutics, 11 (2). pp. 391-396.

Mehling, M. and Burgener, A. V. and Brinkmann, V. and Bantug, G. R. and Dimeloe, S. and Hoenger, G. and Kappos, L. and Hess, C.. (2015) Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade. Scandinavian Journal of Immunology, 82 (5). pp. 460-466.

Mehling, M. and Frank, T. and Albayrak, C. and Tay, S.. (2015) Real-time tracking, retrieval and gene expression analysis of migrating human T cells. Lab on a Chip, 15 (5). pp. 1276-1283.

Kappos, L. and Mehling, M. and Arroyo, R. and Izquierdo, G. and Selmaj, K. and Curovic-Perisic, V. and Keil, A. and Bijarnia, M. and Singh, A. and von Rosenstiel, P.. (2015) Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis. Neurology, 84 (9). pp. 872-879.

2014

Hegen, H. and Millonig, A. and Bertolotto, A. and Comabella, M. and Giovanonni, G. and Guger, M. and Hoelzl, M. and Khalil, M. and Killestein, J. and Lindberg, R. and Malucchi, S. and Mehling, M. and Montalban, X. and Polman, C. and Rudzki, D. and Schautzer, F. and Sellebjerg, F. and Sorensen, P. and Deisenhammer, F.. (2014) Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Multiple sclerosis, Vol. 20, H. 5. pp. 577-587.

Mehling, Matthias and Eichin, Dominik and Hafner, Patricia and Hönger, Gideon and Kappos, Ludwig and Hess, Christoph. (2014) Avidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MS. Neurol Neuroimmunol Neuroinflamm, 1 (3). e28.

2013

Mehling, M. and Brinkmann, V. and Burgener, A. V. and Gubser, P. and Luster, A. D. and Kappos, L. and Hess, C.. (2013) Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade. Journal of allergy and clinical immunology, Vol. 131, H. 5 , S. 1440-1443 e7.

Mehling, M. and Fritz, S. and Hafner, P. and Eichin, D. and Yonekawa, T. and Klimkait, T. and Lindberg, R. L. and Kappos, L. and Hess, C.. (2013) Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNbeta-Therapy. PLoS ONE, Vol. 8, H. 11 , e78532.

2012

Gensicke, H. and Leppert, D. and Yaldizli, O. and Lindberg, R. L. and Mehling, M. and Kappos, L. and Kuhle, J.. (2012) Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis. CNS Drugs, 26 (1). pp. 11-37.

2011

Mehling, M. and Johnson, T. A. and Antel, J. and Kappos, L. and Bar-Or, A.. (2011) Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology, Vol. 76, H. 8, Suppl. 3 , S20-S27.

Kuhle, J. and Leppert, D. and Petzold, A. and Regeniter, A. and Schindler, C. and Mehling, M. and Anthony, D. C. and Kappos, L. and Lindberg, R. L.. (2011) Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology, Vol. 76, H. 14. pp. 1206-1213.

Mehling, M. and Hilbert, P. and Fritz, S. and Durovic, B. and Eichin, D. and Gasser, O. and Kuhle, J. and Klimkait, T. and Lindberg, R. L. P. and Kappos, L. and Hess, C.. (2011) Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. Annals of neurology, Vol. 69, H. 2. pp. 408-413.

Mehling, M. and Kappos, L. and Derfuss, T.. (2011) Fingolimod for multiple sclerosis : mechanism of action, clinical outcomes, and future directions. Current neurology and neuroscience reports, Vol. 11, H. 5. pp. 492-497.

Benz, N. and Daikeler, T. and Frank, S. and Mehling, M. and Tyndall, A. and Trendelenburg, M.. (2011) Three cases of primary small vessel vasculitis of the skeletal muscle-an own entity. BMJ case reports, 2011, Nov 8.